GeneDx Holdings Corp. financial data

Symbol
WGS, WGSWW on Nasdaq
Industry
Services-Health Services
Location
333 Ludlow Street, North Tower, 6 Th Floor, Stamford, CT
State of incorporation
DE
Fiscal year end
December 31
Former names
Sema4 Holdings Corp. (to 1/5/2023), CM Life Sciences, Inc. (to 7/21/2021)
Latest financial report
10-K - Q4 2024 - Feb 20, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 283 % +11.2%
Quick Ratio 17.3 % +35.9%
Debt-to-equity 89.4 % +31.8%
Return On Equity -24.6 % +61.3%
Return On Assets -13 % +65.7%
Operating Margin -7.6 % +91.5%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 28.1M shares
Common Stock, Shares, Outstanding 28M shares +7.84%
Entity Public Float 432M USD +350%
Common Stock, Value, Issued 2K USD 0%
Weighted Average Number of Shares Outstanding, Basic 26.9M shares +10.6%
Weighted Average Number of Shares Outstanding, Diluted 26.9M shares +10.6%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 305M USD +50.8%
Research and Development Expense 45.7M USD -21.5%
Selling and Marketing Expense 67.4M USD +10.5%
General and Administrative Expense 101M USD -24.4%
Operating Income (Loss) -23.2M USD +87.1%
Nonoperating Income (Expense) -29.4M USD -854%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -52.6M USD +70.2%
Income Tax Expense (Benefit) -343K USD +63%
Net Income (Loss) Attributable to Parent -52.3M USD +70.3%
Earnings Per Share, Basic -1.94 USD/shares +73.2%
Earnings Per Share, Diluted -1.94 USD/shares +73.2%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 85.2M USD -14.5%
Marketable Securities, Current 56M USD +83.7%
Cash, Cash Equivalents, and Short-term Investments 114M USD
Accounts Receivable, after Allowance for Credit Loss, Current 32.9M USD -12.6%
Inventory, Net 10.7M USD +21.3%
Other Assets, Current 1.08M USD -44.9%
Assets, Current 198M USD +8.57%
Property, Plant and Equipment, Net 32.9M USD +1.28%
Operating Lease, Right-of-Use Asset 25.6M USD -4.78%
Intangible Assets, Net (Excluding Goodwill) 159M USD -8.13%
Other Assets, Noncurrent 4.31M USD -2.43%
Assets 419M USD +0.15%
Accounts Payable, Current 7.95M USD -22.3%
Accrued Liabilities, Current 11.5M USD -5.54%
Liabilities, Current 54.8M USD -6.8%
Deferred Income Tax Liabilities, Net 965K USD -38.1%
Operating Lease, Liability, Noncurrent 42.7M USD -3.89%
Other Liabilities, Noncurrent 5.52M USD -62.5%
Liabilities 174M USD -8.71%
Accumulated Other Comprehensive Income (Loss), Net of Tax 830K USD +95.3%
Retained Earnings (Accumulated Deficit) -1.35B USD -4.02%
Stockholders' Equity Attributable to Parent 245M USD +7.56%
Liabilities and Equity 419M USD +0.15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -16.4M USD +70.5%
Net Cash Provided by (Used in) Financing Activities -438K USD -100%
Net Cash Provided by (Used in) Investing Activities 843K USD
Common Stock, Shares Authorized 1B shares 0%
Common Stock, Shares, Issued 28M shares +7.84%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -16M USD -121%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 86.2M USD -14.4%
Interest Paid, Excluding Capitalized Interest, Operating Activities 2.02M USD +246%
Deferred Tax Assets, Valuation Allowance 272M USD +0.26%
Deferred Tax Assets, Gross 318M USD -2.72%
Operating Lease, Liability 45.3M USD -3.11%
Payments to Acquire Property, Plant, and Equipment 443K USD
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -51.9M USD +70.4%
Lessee, Operating Lease, Liability, to be Paid 62.3M USD -6.62%
Property, Plant and Equipment, Gross 85.4M USD +8.16%
Operating Lease, Liability, Current 2.61M USD +11.9%
Lessee, Operating Lease, Liability, to be Paid, Year Two 6.29M USD +1.4%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.2M USD +41.3%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 17M USD -14.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 6.26M USD -0.52%
Deferred Tax Assets, Operating Loss Carryforwards 257M USD -0.35%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 1M shares 0%
Unrecognized Tax Benefits 718K USD 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 6.45M USD +2.89%
Operating Lease, Payments 346K USD -72%
Additional Paid in Capital 1.6B USD +4.52%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 7.9M USD -59.9%
Deferred Tax Assets, Net of Valuation Allowance 45.3M USD -17.5%
Share-based Payment Arrangement, Expense 9.14M USD
Interest Expense 3M USD +0.47%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%